BRO's Project Deepak celebrates 66th Raising Day (See 'Corp Brief') IPR - Appellant is a portal that reproduces university rankings & information available in public domain without alteration, editorial bias, or disparaging commentary - no interim injunction: HC (See 'Legal Desk') Capital Market - If allegation of insider trading under SEBI (PIT) Regulations, 2015 failed entirely, there is no contravention of SEBI Act: SAT (See 'Legal Desk') India witnesses Historic Expansion in Social Security: Mandaviya (See 'Corp Brief') Health Ministry releases RBSK 2.0 Guidelines at National Summit on Best Practices (See 'Corp Brief') NHAI successfully launches India's first Multi-Lane Free Flow Tolling System (See 'Corp Brief') IBC - Since MPID Act falls within State legislative field and attachment mechanism under MPID Act, especially where property already stands attached and vested in State, cannot be overridden by invoking Sec 238 or Sec 96 of IBC: HC (See 'Legal Desk') Goyal congratulates IIFT on 63rd Foundation Day (See 'Corp Brief') Outreach workshop on Atmanirbhar Panchayat Programme held at NIRD&PR, Hyderabad (See 'Corp Brief') Hyderabad should emerge as Global Hub for Yoga and Wellness: Reddy (See 'Corp Brief') IBC - If CIRP period expires without approved resolution plan, separate CoC resolution approving liquidation by 66% voting share is not required for Adjudicating Authority to order liquidation u/s 33(1)(a): NCLAT (See 'Legal Desk') Reining in Misuse of IBC for Recovery (See CORP EINSICHT)

Print

Phoenix Parentco acquires Parexel International; CCI okays

Published: Oct 26, 2021

By TIOLCorplaws News Service

NEW DELHI, OCT 26, 2021: THE Competition Commission of India (CCI) approves acquisition of Parexel International Corporation by Phoenix Parentco, Inc. The proposed combination envisages acquisition of 100% of the equity shareholding of Parexel International Corporation (Target) by Phoenix Parentco, Inc. (Acquirer). The Acquirer is jointly controlled by EQT Fund Management S.a r.l. (EQT) and the Goldman Sachs Group, Inc. (Goldman Sachs). The Target is headquartered in Durham, USA. It provides biopharmaceutical outsourcing services to biopharmaceutical companies. The global activities of Target can be categorised into broad segments viz. clinical solutions and consulting.

Detailed order of the CCI will follow.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.